These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19697270)

  • 1. Cancer-BIT Life Sciences' second world congress. 22-25 June 2009, Beijing, China.
    McKeown S
    IDrugs; 2009 Sep; 12(9):543-6. PubMed ID: 19697270
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting transcription factors for cancer therapy.
    Frank DA
    IDrugs; 2009 Jan; 12(1):29-33. PubMed ID: 19127502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies: the answer to individualized treatment?
    Hutchinson L
    Nat Clin Pract Oncol; 2007 Jun; 4(6):323. PubMed ID: 17534387
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.
    Fine BM; Amler L
    Clin Pharmacol Ther; 2009 May; 85(5):535-8. PubMed ID: 19295504
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug resistance: a growing problem.
    Peet NP
    Drug Discov Today; 2010 Aug; 15(15-16):583-6. PubMed ID: 20434584
    [No Abstract]   [Full Text] [Related]  

  • 7. Medichem--BIT Life Sciences' First Annual International Conference.
    Corson TW
    IDrugs; 2010 Jul; 13(7):453-6. PubMed ID: 20582869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference screening for the discovery of oncology targets.
    Quon K; Kassner PD
    Expert Opin Ther Targets; 2009 Sep; 13(9):1027-35. PubMed ID: 19650760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of type 3 deiodinase in cancer.
    Dentice M; Ambrosio R; Salvatore D
    Expert Opin Ther Targets; 2009 Nov; 13(11):1363-73. PubMed ID: 19764892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview. Cancer drug discovery: pathway promise or covalent certainty for drug effect--quo vadis?
    Sausville EA
    Curr Opin Investig Drugs; 2000 Dec; 1(4):511-3. PubMed ID: 11249707
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting the EGF receptor ectodomain in the context of cancer.
    Huang L; De Baetselier P; Beyaert R
    Expert Opin Ther Targets; 2009 Nov; 13(11):1347-61. PubMed ID: 19769546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.
    Roukos DH; Tzakos A; Zografos G
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1413-6. PubMed ID: 19828000
    [No Abstract]   [Full Text] [Related]  

  • 13. IUPHAR 2006--15th World Congress of Pharmacology. Metalloproteinases as Therapeutical Targets for Cancer Therapy. 2-7 July 2006, Beijing, China.
    Pei D
    IDrugs; 2006 Sep; 9(9):598-9. PubMed ID: 16952061
    [No Abstract]   [Full Text] [Related]  

  • 14. Nanodiamonds as vehicles for systemic and localized drug delivery.
    Lam R; Ho D
    Expert Opin Drug Deliv; 2009 Sep; 6(9):883-95. PubMed ID: 19637985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 41st IUPAC World Chemistry Congress. 5-11 August 2007, Turin, Italy.
    Schettino V
    IDrugs; 2007 Oct; 10(10):706-8. PubMed ID: 17899488
    [No Abstract]   [Full Text] [Related]  

  • 16. [Possible application of lectins in diagnostics and therapy. Part II].
    Końska G; Wójtowicz U; Pituch-Noworolska A
    Przegl Lek; 2008; 65(5):252-5. PubMed ID: 18853653
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics in the elderly.
    Lichtman SM
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):181-2. PubMed ID: 17519878
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation initiation: a critical signalling node in cancer.
    Robert F; Pelletier J
    Expert Opin Ther Targets; 2009 Nov; 13(11):1279-93. PubMed ID: 19705976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally advanced rectal cancer: from molecular profiling to clinical practice. A literature review: Part 2.
    Berardi R; Maccaroni E; Onofri A; Giampieri R; Pistelli M; Bittoni A; Scartozzi M; Pierantoni C; Mandolesi A; Bearzi I; Cascinu S
    Expert Opin Pharmacother; 2009 Oct; 10(15):2467-78. PubMed ID: 19761354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.